NDT Pharmaceuticals, Inc. is a development stage company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2006-12-14. The firm is focused on the development of therapies for severe neurological disorders associated with traumatic brain Injury. The Company’s nanoscale particle complex (NPC) technology represents the edge of phospholipid-based nano-encapsulation delivery systems, which is approximately 100 nanometers in diameter; mean diameter of approximately 40 nanometers in liquid product samples with the capability to engineer significantly smaller nanocarrier particles, which creates delivery of payloads into the bloodstream, beginning through the membranes of the mouth. The NPC technology also incorporates an ingredient, which stimulates repair of damaged cell tissue, Cell Armor.

Industry: Metal Mining Peers: Teck Resources Ltd